Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis

Jean A. Patel*, Susan M. Pacheco, Michael Postelnick, Sarah Sutton

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Purpose. A case of persistent multidrugresistant (MDR) Acinetobacter baumannii ventriculitis successfully treated with a prolonged and novel combination of antimicrobials is reported. Summary. A 38-year-old, 84-kg Caucasian woman with a recent history of craniotomy was admitted with nausea, fever, headache, photophobia, and drainage from her craniotomy incision. She underwent a repeat craniotomy on hospital day 4 with abscess debridement and repair of a cerebrospinal fluid leak. Cultures grew MDR A. baumannii, coagulase-negative Staphylococcus species, and methicillin-resistant Staphylococcus aureus. Based on the limited published pharmacokinetic and pharmacodynamic data for colistin, we determined a favorable outcome with i.v. colistin monotherapy was unlikely and decided to treat the patient with simultaneous i.v. and intraventricular colistin, as well as intraventricular tobramycin and i.v. rifampin. She was treated with a total of 36 days of intraventricular colistin, 40 days of intraventricular tobramycin, 51 days of i.v. colistin and rifampin, and56 days i.v. vancomycin for infection that persisted despite multiple debridements. The patient had subsequent improvement in clinical manifestations and eradication of infection. She was subsequently discharged to an acute rehabilitation facility on hospital day 77 with posttreatment sequelae including mental impairment and renal failure requiring hemodialysis. Follow-up visits revealed significant improvement in her mental status, speech, and strength on the side not affected by the stroke. Conclusion. Prolonged combination therapy with intraventricular colistin and tobramycin plus i.v. colistin, rifampin, and vancomycin led to the resolution of a persistent central nervous system infection caused by MDR A. baumannii.

Original languageEnglish (US)
Pages (from-to)1527-1531
Number of pages5
JournalAmerican Journal of Health-System Pharmacy
Volume68
Issue number16
DOIs
StatePublished - Aug 15 2011

Keywords

  • Acinetobacter baumanii
  • Acinetobacter infections
  • Aminoglycosides
  • Antibiotics
  • Antiinfective agents
  • Cerebral ventriculitis
  • Colistin
  • Combined therapy
  • Resistance
  • Rifampin
  • Tobramycin
  • Vancomycin

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy

Fingerprint Dive into the research topics of 'Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis'. Together they form a unique fingerprint.

Cite this